Wockhardt Ltd. (WOCKPHARMA): Wockhardt Share Price Falls 3.25% Today: Price Action, Sector and Peer View

Wockhardt Share Price is in focus on 12 August 2026 after the stock fell to Rs 1,844.8, down Rs 62 or 3.25% for the day, taking the company’s market capitalisation to Rs 31,403.24 crore. The move put Wockhardt among notable stocks in news during today’s session, especially because the decline was deep enough for a threshold-based Large Cap top decliner screen.

The verified data confirms the price fall, the intraday weakness and the trading activity, but it does not establish a company-specific catalyst behind the decline. That distinction matters. In stock market today coverage, many names trend because of visible price action alone, and Wockhardt Share Price Today is one of those cases where the market move itself is clear even though the supplied data does not tie it to a specific announcement.

For investors tracking Wockhardt Stock News, the key numbers are straightforward. The stock opened at Rs 1,909.95, touched a day high of Rs 1,910.25, then weakened sharply to a day low of Rs 1,844.65 before trading at Rs 1,844.8. Total volume stood at 5,64,890 shares across exchanges, including 5,28,564 on NSE and 36,326 on BSE, while turnover was Rs 6.7 crore. What investors may want to monitor next is whether this price action remains isolated to one session or starts affecting relative positioning versus Healthcare sector peers tracked by Univest.

Wockhardt Ltd. (WOCKPHARMA) Share Price Today: Price Action Analysis

Wockhardt Ltd. (WOCKPHARMA) traded at Rs 1,844.8. versus the previous close of Rs 1,906.8, a fall of 3.25%. The stock opened at Rs 1,909.95, reached Rs 1,910.25, touched Rs 1,844.65. Reported volume was 36,326.

Wockhardt Ltd. (WOCKPHARMA) Fundamental Analysis

Wockhardt Fundamental Analysis, based strictly on the supplied data, begins with scale and market positioning. At a market capitalisation of Rs 31,403.24 crore, Wockhardt is far larger than the supplied Healthcare sector benchmark set, where the median market capitalisation is Rs 142.81 crore and the average is Rs 461.64 crore across 196 companies. Even the highest market capitalisation within that benchmark snapshot is Rs 2,949.87 crore, well below Wockhardt’s current size. That does not by itself indicate quality or valuation comfort, but it does show that Wockhardt occupies a very different size bracket from most companies in the comparison universe.

That size gap matters for investors reading Wockhardt Stock News because large market capitalisation stocks often attract attention differently from smaller peers. A 3.25% decline in a Rs 31,403.24 crore company can stand out more in share market today coverage than a similar percentage move in a much smaller stock. In practical terms, Wockhardt Share Price carries weight because the company sits above the sector benchmark’s average and median by a very wide margin.

The sector valuation backdrop also offers context. Within the same Healthcare sector benchmark, 156 companies contribute to the P/E data set, producing a median P/E of 25.58 and an average of 81.68, with a range from 3.31 to 3,374.81. On price-to-book, 195 companies produce a median of 1.9 and an average of 2.6, with values ranging from -16.74 to 16.32. Profitability in the same benchmark shows a median ROE of 11.07 and average ROE of 15.45 from 195 companies, while ROCE stands at a median of 13.35 and average of 17.8 from 195 companies. For Univest readers, that benchmark does not explain today’s fall by itself, but it helps frame the environment in which Wockhardt Share Price is being assessed. The next layer to examine is how that positioning compares with sector peers and market structure.

Sector and Industry Context

Wockhardt Ltd. (WOCKPHARMA) is classified under sector: Healthcare.

Track today’s top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Wockhardt operates in Healthcare, and the broader benchmark snapshot shows a wide valuation and profitability spread across the sector. That matters because today’s share price decline is unfolding in a segment where companies can trade at very different multiples, returns and market-cap scales even within the same broad classification.

The supplied benchmark scope is the same sector, covering 196 companies. In that universe, P/E data is available for 156 companies, with a median of 25.58 and an average of 81.68. The range is especially broad, from 3.31 at the low end to 3,374.81 at the high end, suggesting that Healthcare names are being priced very differently depending on business mix, profitability profile and investor expectations. For price-to-book, 195 companies are included, showing a median of 1.9 and average of 2.6, with a range from -16.74 to 16.32.

Return metrics also underline how uneven the sector can be. The median ROE is 11.07 and the average is 15.45 across 195 companies, while ROCE shows a median of 13.35 and average of 17.8 across the same count. Meanwhile, market-cap distribution is highly skewed, with a median of Rs 142.81 crore, average of Rs 461.64 crore, a minimum of Rs 3.88 crore and a maximum of Rs 2,949.87 crore within the benchmark set. Against that backdrop, Wockhardt’s market capitalisation of Rs 31,403.24 crore stands out as materially larger than the benchmark range itself. For readers following Wockhardt Share Price and Wockhardt Share Price Today on Univest, that contrast explains why a one-day decline in this stock can attract disproportionate attention in Indian stock market coverage even without a verified company-specific trigger in the supplied data.

Peer Comparison

Wockhardt Ltd. (WOCKPHARMA) has a market capitalisation of Rs 31,403.24 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Wockhardt’s peer context in the supplied Healthcare universe shows a mixed operating and valuation landscape rather than a single clear template. The listed comparison set includes Dishman Carbogen Amcis, Beta Drugs, Hikal, Sai Parenteral’s, Dr Agarwals Eye Hospital, Solara Active Pharma Sciences, Panacea Biotec, NGL Fine-Chem, Hester Biosciences and Ind-Swift Laboratories. Their market capitalisations range from Rs 2,061.86 crore for Ind-Swift Laboratories to Rs 2,949.87 crore for Dishman Carbogen Amcis within this sample, again underlining how much larger Wockhardt is at Rs 31,403.24 crore.

On valuation, the peer group shows substantial variation. Dishman Carbogen Amcis trades at a P/E of 31.07 and P/B of 0.45, Beta Drugs at 71.31 P/E and 11.28 P/B, Sai Parenteral’s at 179.52 P/E and 3.32 P/B, Dr Agarwals Eye Hospital at 33.61 P/E and 6.93 P/B, NGL Fine-Chem at 44.41 P/E and 6.49 P/B, Hester Biosciences at 15.51 P/E and 4.64 P/B, and Ind-Swift Laboratories at 43.16 P/E and 1.65 P/B. Other peers in the snapshot such as Hikal, Solara Active Pharma Sciences and Panacea Biotec are also represented through P/B and return ratios.

Profitability is equally dispersed. Beta Drugs shows ROE of 18.65 and ROCE of 22.17, NGL Fine-Chem posts ROE of 27.9 and ROCE of 33.91, Hikal reports ROE of 15.22 and ROCE of 16.15, while Panacea Biotec shows ROE of 0 and ROCE of 5.36. Dishman Carbogen Amcis has ROE of -2.89 and ROCE of -0.26, and Dr Agarwals Eye Hospital shows ROE of -2.6 with ROCE of 16.92. This spread highlights why investors should avoid reading today’s Wockhardt Share Price fall as a simple sector-wide template. In Healthcare, peers can sit on very different valuation and return profiles even when they are grouped together in a single stock analysis screen on Univest.

Why Investors Are Watching Wockhardt

Wockhardt Share Price is being watched because today’s decline combines a notable percentage fall with end-of-range weakness, meaningful turnover and a market-cap profile that is much larger than the benchmark companies shown in the same Healthcare comparison set. That combination makes the stock relevant not only in Wockhardt Latest News tracking but also in broader market movers and top decliner screens.

• Price action: The stock fell 3.25%, from Rs 1,906.8 to Rs 1,844.8, after opening at Rs 1,909.95 and sliding toward a low of Rs 1,844.65.
• Intraday structure: The day high was Rs 1,910.25, so most of the session’s move reflected downside price action rather than recovery.
• Trading activity: Total volume reached 5,64,890 shares, including 5,28,564 on NSE and 36,326 on BSE, with turnover of Rs 6.7 crore.
• Market scale: Wockhardt’s market capitalisation is Rs 31,403.24 crore, far above the same-sector benchmark median and average.
• Sector context: Healthcare benchmark metrics show wide spreads in P/E, P/B, ROE and ROCE, which can amplify stock-specific attention during a market decline.

What investors may monitor next is whether Wockhardt Share Price stabilises away from the day low, whether trading activity remains elevated in coming sessions, and whether relative sector positioning changes as more market data develops. For now, the verified picture is a significant one-day decline in a large company rather than a fully explained fundamental shift.

About Wockhardt

Wockhardt Ltd. is represented in the supplied market data as a Healthcare company, and its peer set places it alongside businesses in Pharmaceuticals & Drugs as well as Hospital & Healthcare Services. That broad sector classification matters for readers following Wockhardt Share Price because Healthcare stocks often draw investor attention through a blend of company-specific developments, sector valuation changes and broader defensive or cyclical market positioning.

The comparison basket around Wockhardt is dominated by pharmaceutical and drug-related companies such as Dishman Carbogen Amcis, Beta Drugs, Hikal, Sai Parenteral’s, Solara Active Pharma Sciences, Panacea Biotec, NGL Fine-Chem, Hester Biosciences and Ind-Swift Laboratories. One peer in the supplied set, Dr Agarwals Eye Hospital, represents Hospital & Healthcare Services, showing that the sector view here is broad rather than limited to one narrow sub-segment. That makes sector interpretation more nuanced, because valuation and profitability patterns can vary across business models even inside Healthcare.

Within this context, Wockhardt’s size stands out. Its market capitalisation of Rs 31,403.24 crore is materially above the benchmark company range shown in the sector snapshot and above the 10 listed peers supplied for direct comparison. For investors reading Wockhardt Company News and Wockhardt Share News on Univest, the company’s significance in market coverage currently comes less from a verified same-day catalyst in the data and more from the scale of the stock, the visible price fall, and its relevance within the Healthcare segment.

Track Wockhardt Share Price on Univest

Use Wockhardt Ltd. (WOCKPHARMA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.

Investors who want to follow Wockhardt Share Price more closely can use Univest to track live price movement, daily share price updates, market capitalisation changes and broader stock performance context. The platform helps users monitor price action across NSE and BSE, compare sector and peer positioning, and keep an eye on how a stock behaves relative to 52-week levels and market trends.

For readers following Wockhardt Share Price Today, Univest also brings together stock analysis tools that make it easier to read volume shifts, benchmark context and company-level market updates in one place. That is useful when a stock enters stocks in news lists because of a sharp daily fall but the available market data does not yet establish a specific trigger. In such cases, disciplined tracking of price, turnover and sector context becomes especially important.

Frequently Asked Questions

Why is Wockhardt Share Price falling today?

Ans. Wockhardt Share Price fell 3.25% today, dropping Rs 62 from the previous close of Rs 1,906.8 to Rs 1,844.8. The supplied market data confirms the decline and intraday weakness, but it does not identify a company-specific catalyst.

What is Wockhardt Share Price Today?

Ans. Wockhardt Share Price Today is Rs 1,844.8. The stock opened at Rs 1,909.95, touched a high of Rs 1,910.25 and a low of Rs 1,844.65, showing that the session weakened sharply from near the opening zone.

How much did Wockhardt stock decline today?

Ans. Wockhardt stock declined by Rs 62 or 3.25% in today’s session. That move took the share price from Rs 1,906.8 at the previous close to Rs 1,844.8, placing it among notable decliners in market action today.

What does today’s intraday price action show for Wockhardt?

Ans. The intraday pattern shows Wockhardt opened at Rs 1,909.95 and rose only marginally to Rs 1,910.25 before sliding to Rs 1,844.65. Trading near the day low suggests selling pressure stayed visible through most of the session.

What is Wockhardt’s market capitalisation?

Ans. Wockhardt’s market capitalisation is Rs 31,403.24 crore. That places it in the Large Cap category in the supplied event framework and makes today’s 3.25% share price decline notable from a market-impact perspective.

How much volume was traded in Wockhardt today?

Ans. Total traded volume in Wockhardt stood at 5,64,890 shares today. This included 5,28,564 shares on NSE and 36,326 shares on BSE, while the supplied turnover figure for the session was Rs 6.7 crore.

Which sector does Wockhardt belong to?

Ans. Wockhardt belongs to the Healthcare sector in the supplied data. The same-sector benchmark covers 196 companies, giving investors a useful frame for comparing market-cap scale, valuation ranges and return metrics around today’s price fall.

How does Wockhardt compare with the Healthcare sector on size?

Ans. Wockhardt is much larger than the supplied Healthcare benchmark set. Its market capitalisation is Rs 31,403.24 crore, versus a sector median of Rs 142.81 crore and average of Rs 461.64 crore across 196 benchmark companies.

Which peers are relevant for Wockhardt in this article?

Ans. The supplied peer set includes Dishman Carbogen Amcis, Beta Drugs, Hikal, Sai Parenteral’s, Dr Agarwals Eye Hospital, Solara Active Pharma Sciences, Panacea Biotec, NGL Fine-Chem, Hester Biosciences and Ind-Swift Laboratories within Healthcare.

What should investors monitor next in Wockhardt Share Price?

Ans. Investors may monitor whether Wockhardt Share Price stabilises away from the day low of Rs 1,844.65, whether trading activity remains elevated after 5,64,890 shares traded today, and how the stock behaves relative to Healthcare sector peers.